Clinical Trial Management System Market - Forecast(2022 - 2027)

Report Code: HCR 0493 Report Format: PDF + Excel

Clinical Trial Management System Market Overview

The clinical trial management system market size is estimated to reach $1.7 billion by 2026. Furthermore, it is poised to grow at a CAGR of 12.4% over the forecast period of 2021-2026. The purpose of CTMS is to electronically capture the data and transfer the information to business intelligence systems, which in turn helps in acting as a digital dashboard for the trial managers. The clinical trial planning stages vary with the phases. As for pre-clinical phases, the trials are conducted on-premises, and the data is relatively easy to store and manage. However, the later stages of the trials are extensive, and government regulative forces the companies involved to comprehensively track the patient’s data; hence companies use the concept of electronic data capture. Owing to their property of being cost-effective, experts can track the volunteers for past trials with the help of centralized data and reduce the time thereby spent to find the suitable candidate. The software systems are extensively being used by biotechnology and pharmaceutical industries to manage clinical trials. The growing number of clinical trials owing to the rise in lifestyle-related ailments along with the ready availability of CRO in the drug development process and other allied services are some of the factors driving the clinical trials management systems industry forward in the projected period of 2021-2026.

Report Coverage

The report: Clinical Trial Management System Market Forecast (2021-2026)”, by Industry ARC covers an in-depth analysis of the following segments of the clinical trial management system market.

By Deployment- Enterprise-wide CTMS and On-site CTMS.
By Delivery- Web-based, Licensed Enterprise, and Cloud Based.
By End Users – Pharmaceutical and Biotechnology, Contract Research Organization, and Medical Device Manufacturers.
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

  • Geographically, North America’s clinical trials management systems industry held a dominant market share in the year 2020. It is owing to the heavy alignment of the government’s budget to the development of effective drugs and vaccines. Additionally, countries like the US has been a leader when it comes to R&D for pharmaceutical deployments. However, Asia-Pacific sets to offer lucrative growth opportunities to marketers. It is owing to the likes of countries like Korea and Japan’s inclination to reduce the dependency on humans and deploy systems that can readily replace the former, and their effectiveness is far superior to the existing technology.
  • A rise in chronic diseases along with the want to develop better medications has acted as a driver for the market. However, owing to various budget constraints and high error rates the market is faced with a grave challenge.
  • A detailed analysis of the strengths, weaknesses, opportunities, and threats will be provided in the Clinical Trial Management System Market report.

    Clinical Trial Management System Market-Geography (%) for 2020.

For More Details on This Report - Request for Sample

Clinical Trial Management System Market Segmentation Analysis - By Deployment

The clinical trial management system market based on the deployment can be further segmented into enterprise-wide CTMS and On-Site CTMS. The enterprise-wide CTMS held a dominant market size in the year 2020. It is owing to the various system capabilities it offers over the former. The core features which are predominantly present in any enterprise vide CTMS includes protocol calendar setup and management, easy enrolment, patient demographic tracking, billing, integrations, and fewer platform restriction. Additionally, the modern enterprise vide CTMS offers fewer logins, easy transitions between data collection and site operations, and lastly eliminates the double data entry, which reduces the time per patient and increases the overall efficiency.

Moreover, the enterprise vide CTMS is estimated to be the fastest-growing, with a CAGR of 12.8% over the forecast period of 2021-2026. It is owing to the vendor’s responsibility to keep track of the system compliance and security. The compliance strategies mostly revolve around electronic data capture EDC systems and document management capabilities which help in distinguishing between the modules. Lastly, as per the advent of SaaS, the enterprise-based CTMS has become easy to incorporate, which has further helped in the growth of this segment.

Clinical Trial Management System Market Segmentation Analysis - By End-Users

The clinical trial management systems market based on the end-users can be further segmented into Pharmaceutical and Biotechnology, Contract Research Organization, and Medical Device Manufacturers. The pharmaceutical and biotechnology segment held a dominant market share in the year 2020. It is owing to the ready budgetary allocation for developing new drugs and medicines, which has resulted in increased R&D spending. As per reports, in 2019, the pharmaceutical industry spent $83 billion on R&D, which is ten times more than what was spent in 1980. 

However, contract research organizations are estimated to be the fastest-growing, with a CAGR of 13.1% over the forecast period of 2021-2026. It is owing to various factors and it helps the big pharmaceutical companies to reduce the total expenditure. As the burden for hiring new research staff and investing in house R&D can mitigate huge amounts of profits. The companies are now trying to achieve low risk-high profit module by transferring works such as immunogenicity, biomarkers, and pharmacokinetics practices to CROs. Additionally, they can handle increasingly complex drugs and clinical trials and overtly reduce the time to market. 

Clinical Trial Management System Market Segmentation Analysis - By Geography

The clinical trial management system market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. Geographically, North America held a dominant market share of 42% as compared to the other regions. It is owing to the leading costs incurred by major medicine makers to contribute to more sustainable and advanced drug discovery. For example, Merck’s R&D costs soared by up to 37% over 2019. Like which other giants such as Incyte and Regeneron, observed higher spending on R&D-related activities, which indeed helped the clinical trial management systems market.

However, Asia-Pacific is set to offer lucrative growth opportunities to marketers. It is owing to the recent advancement and adoption of IoT and cloud-based systems in healthcare infrastructure. Additionally, economies such as Korea, Japan, and India are now spending a majority of their GDP to help in advancing the overall healthcare setup. The following regions will observe increased research-based activities, which will help in the development of clinical trial management system markets.

Clinical Trial Management System Market Drivers

The rising number of clinical trials has readily supplanted the need for the clinical trial management systems market

The pharmaceutical companies have been squadron leaders in terms of adapting to the latest technology. Now more than ever, there has been a steady increase in the number of clinical trial phases. Especially after the COVID-19, companies have become more agile to implement easy-fast-efficient processes, which have aided the growth of the clinical trial management systems market. A cross comparative study has been analyzed, which depicts that in 2018, around 2,85,679 clinical trials were conducted across the 50 states of the US. However, the numbers have increased to 3,58,156 as of 2020. The following has exhibited an increase of 25% YoY, and the growth is expected to continue owing to better facilities across countries using the likes of IoT and others.

The rising burden of chronic illness has and will support the growth of the clinical trial management systems market

The number of chronic illnesses such as diabetes, pulmonary ailments, and various types of cardiovascular diseases has been growing at a steadfast pace. It is primarily owing to the sedentary lifestyle and growing urbanization trends across the globe. As per the analysis of GACD in 2018, one in ten individuals will have type-2 diabetes by 2035, and additionally, it would be the seventh leading cause of death by 2030. Moreover, the geriatric population worldwide is estimated to break even with the younger adults by 2034 in the countries like the US and Japan. The rising geriatric population will further allow the increase in the prevalence of type two diabetes. The increase in the rising illnesses has propelled the companies to find new and better drugs, which has increased and will increase the number of clinical trials and the associated clinical trial management systems market.

Clinical Trial Management System Market Challenges

The budgetary constraints, along with the lack of skilled professionals, have hampered the growth of the market

The probability of making it to the later stages by getting approvals from regulatory bodies is extremely low. For example, as per various studies, only 32% of the drugs sail through to the Phase-III trial. Moreover, only 10% of the drugs make it to the market. A failed clinical trial can cost companies billions of dollars, additionally, companies face the wrath of stock market prices, which in turn reduces the number of research sites, and in worse situations, businesses have to sell off their therapeutic areas to conserve their core business areas. The wrath of budgetary constraints is mostly faced by the market entrants, as the failed product launch impedes them to adapt to modern CTMS solutions and further stops them from training new employees to use technologies across.

Clinical Trial Management System Market Competitive Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the clinical trial management system market. The top 10- clinical trial management system market companies include:

  1. Oracle Corporation
  2. Medidata Solutions
  3. Parexel International
  4. Bioclinicia
  5. IBM
  6. MedNet Solutions
  7. DataStat
  8. Calyx
  9. Bio-Optronics
  10. Veeva Systems

Recent Developments

  • In December 2020, ERT introduced Data Insights. The platform has been launched to remove the endpoint data variabilities. The program relies on using diagnostic, predictive, and prescriptive analytics. Moreover, it allows the user to weigh metrics and customize notifications on data quality thresholds. Lastly, the customers get 24/7 multi-lingual customer care support that can help them sort data into portfolios.
  • In January 2020, Veeva Systems introduced their add-on application- Veeva Vault Payments. It is being added to the platform’s CTMS application- Veeva Vault CTMS. The following helps in managing the on-site payments with ease. It allows complete visibility over study partners. The payments are automated, hence, the CROs and sponsors can pay sites accordingly.

Relevant Titles

Artificial Intelligence Market in Healthcare- Forecast (2021-2026)
Report Code- ITR 0095

Point of Care Diagnostics Market- Forecast (2021-2026)
Report Code- HCR 0021

For more Lifesciences and Healthcare related reports, please click here

1. Clinical Trial Management System Market- Overview
    1.1 Definitions and Scope
2. Clinical Trial Management System Market- Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends by Deployment
    2.3 Key trends by Delivery
    2.4 Key trends by Geography
3. Clinical Trial Management System Market- Comparative Analysis
    3.1 Company Benchmarking – Key Companies
    3.2 Financial Analysis– Key Companies
    3.3 Market Share Analysis– Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Clinical Trial Management System Market- Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Clinical Trial Management System Market– Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Clinical Trial Management System Market- Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Clinical Trial Management System Market– Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Clinical Trial Management System Market– By Deployment (Market Size –$Million/$Billion)
    8.1 Enterprise-wide CTMS
    8.2 On-site CTMS
9. Clinical Trial Management System Market– By Delivery (Market Size –$Million/$Billion)
    9.1 Web-based (On Demand)
    9.2 Licensed Enterprise (On Premise)
    9.3 Cloud Based (SaaS)
10. Clinical Trial Management System Market– By End Users (Market Size –$Million/$Billion)
    10.1 Pharmaceutical and Biotechnology 
    10.2 Contract Research Organization
    10.3 Medical Device Manufacturer
    10.4 Others
11. Clinical Trial Management System Market- By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Clinical Trial Management System Market- Entropy
13. Clinical Trial Management System Market– Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Competition Matrix
        13.1.5 Best Practices for Companies
14. Clinical Trial Management System Market– Key Company List by Country Premium Premium
15. Clinical Trial Management System Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.